428 related articles for article (PubMed ID: 19607756)
1. Inhibition of fatty-acid amide hydrolase and CB1 receptor antagonism differentially affect behavioural responses in normal and PCP-treated rats.
Seillier A; Advani T; Cassano T; Hensler JG; Giuffrida A
Int J Neuropsychopharmacol; 2010 Apr; 13(3):373-86. PubMed ID: 19607756
[TBL] [Abstract][Full Text] [Related]
2. Phencyclidine-induced social withdrawal results from deficient stimulation of cannabinoid CB₁ receptors: implications for schizophrenia.
Seillier A; Martinez AA; Giuffrida A
Neuropsychopharmacology; 2013 Aug; 38(9):1816-24. PubMed ID: 23563893
[TBL] [Abstract][Full Text] [Related]
3. Cannabinoid CB1 receptor antagonism prevents neurochemical and behavioural deficits induced by chronic phencyclidine.
Guidali C; Viganò D; Petrosino S; Zamberletti E; Realini N; Binelli G; Rubino T; Di Marzo V; Parolaro D
Int J Neuropsychopharmacol; 2011 Feb; 14(1):17-28. PubMed ID: 20196921
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of fatty acid amide hydrolase modulates anxiety-like behavior in PCP-treated rats.
Seillier A; Giuffrida A
Pharmacol Biochem Behav; 2011 Jun; 98(4):583-6. PubMed ID: 21421000
[TBL] [Abstract][Full Text] [Related]
5. The cannabinoid transporter inhibitor OMDM-2 reduces social interaction: Further evidence for transporter-mediated endocannabinoid release.
Seillier A; Giuffrida A
Neuropharmacology; 2018 Mar; 130():1-9. PubMed ID: 29169961
[TBL] [Abstract][Full Text] [Related]
6. Disruption of social cognition in the sub-chronic PCP rat model of schizophrenia: Possible involvement of the endocannabinoid system.
Seillier A; Giuffrida A
Eur Neuropsychopharmacol; 2016 Feb; 26(2):298-309. PubMed ID: 26706691
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of fatty acid amide hydrolase reverses aberrant prefrontal gamma oscillations in the sub-chronic PCP model for schizophrenia.
Seillier A
Exp Brain Res; 2024 May; 242(5):1149-1160. PubMed ID: 38489023
[TBL] [Abstract][Full Text] [Related]
8. An endocannabinoid signaling system modulates anxiety-like behavior in male Syrian hamsters.
Moise AM; Eisenstein SA; Astarita G; Piomelli D; Hohmann AG
Psychopharmacology (Berl); 2008 Oct; 200(3):333-46. PubMed ID: 18545985
[TBL] [Abstract][Full Text] [Related]
9. Genetic impairment of frontocortical endocannabinoid degradation and high alcohol preference.
Hansson AC; Bermúdez-Silva FJ; Malinen H; Hyytiä P; Sanchez-Vera I; Rimondini R; Rodriguez de Fonseca F; Kunos G; Sommer WH; Heilig M
Neuropsychopharmacology; 2007 Jan; 32(1):117-26. PubMed ID: 16482090
[TBL] [Abstract][Full Text] [Related]
10. Anti-aversive role of the endocannabinoid system in the periaqueductal gray stimulation model of panic attacks in rats.
Viana TG; Hott SC; Resstel LB; Aguiar DC; Moreira FA
Psychopharmacology (Berl); 2015 May; 232(9):1545-53. PubMed ID: 25388290
[TBL] [Abstract][Full Text] [Related]
11. Involvement of the endocannabinoid system in retinal damage after high intraocular pressure-induced ischemia in rats.
Nucci C; Gasperi V; Tartaglione R; Cerulli A; Terrinoni A; Bari M; De Simone C; Agrò AF; Morrone LA; Corasaniti MT; Bagetta G; Maccarrone M
Invest Ophthalmol Vis Sci; 2007 Jul; 48(7):2997-3004. PubMed ID: 17591864
[TBL] [Abstract][Full Text] [Related]
12. Dysregulation of the endogenous cannabinoid system in adult rats prenatally treated with the cannabinoid agonist WIN 55,212-2.
Castelli MP; Paola Piras A; D'Agostino A; Pibiri F; Perra S; Gessa GL; Maccarrone M; Pistis M
Eur J Pharmacol; 2007 Nov; 573(1-3):11-9. PubMed ID: 17644084
[TBL] [Abstract][Full Text] [Related]
13. FAAH-/- mice display differential tolerance, dependence, and cannabinoid receptor adaptation after delta 9-tetrahydrocannabinol and anandamide administration.
Falenski KW; Thorpe AJ; Schlosburg JE; Cravatt BF; Abdullah RA; Smith TH; Selley DE; Lichtman AH; Sim-Selley LJ
Neuropsychopharmacology; 2010 Jul; 35(8):1775-87. PubMed ID: 20357755
[TBL] [Abstract][Full Text] [Related]
14. Inhibitors of monoacylglycerol lipase, fatty-acid amide hydrolase and endocannabinoid transport differentially suppress capsaicin-induced behavioral sensitization through peripheral endocannabinoid mechanisms.
Spradley JM; Guindon J; Hohmann AG
Pharmacol Res; 2010 Sep; 62(3):249-58. PubMed ID: 20416378
[TBL] [Abstract][Full Text] [Related]
15. Manipulation of fatty acid amide hydrolase functional activity alters sensitivity and dependence to ethanol.
Vinod KY; Sanguino E; Yalamanchili R; Manzanares J; Hungund BL
J Neurochem; 2008 Jan; 104(1):233-43. PubMed ID: 17944864
[TBL] [Abstract][Full Text] [Related]
16. Endocannabinoid modulation of amphetamine sensitization is disrupted in a rodent model of lesion-induced dopamine dysregulation.
Eisenstein SA; Holmes PV; Hohmann AG
Synapse; 2009 Nov; 63(11):941-50. PubMed ID: 19593824
[TBL] [Abstract][Full Text] [Related]
17. Role of the endocannabinoid system in the dorsal hippocampus in the cardiovascular changes and delayed anxiety-like effect induced by acute restraint stress in rats.
Hartmann A; Fassini A; Scopinho A; Correa FM; Guimarães FS; Lisboa SF; Resstel LB
J Psychopharmacol; 2019 May; 33(5):606-614. PubMed ID: 30789299
[TBL] [Abstract][Full Text] [Related]
18. Cannabidiol disrupts the consolidation of specific and generalized fear memories via dorsal hippocampus CB
Stern CAJ; da Silva TR; Raymundi AM; de Souza CP; Hiroaki-Sato VA; Kato L; Guimarães FS; Andreatini R; Takahashi RN; Bertoglio LJ
Neuropharmacology; 2017 Oct; 125():220-230. PubMed ID: 28754373
[TBL] [Abstract][Full Text] [Related]
19. Distinct neuronal activation patterns are associated with PCP-induced social withdrawal and its reversal by the endocannabinoid-enhancing drug URB597.
Matricon J; Seillier A; Giuffrida A
Neurosci Res; 2016 Sep; 110():49-58. PubMed ID: 27091613
[TBL] [Abstract][Full Text] [Related]
20. Chronic treatment with URB597 ameliorates post-stress symptoms in a rat model of PTSD.
Fidelman S; Mizrachi Zer-Aviv T; Lange R; Hillard CJ; Akirav I
Eur Neuropsychopharmacol; 2018 May; 28(5):630-642. PubMed ID: 29519609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
